NASDAQ:CLXT - Calyxt Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $9.33
  • Forecasted Upside: 78.46 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$5.23
▼ -0.12 (-2.24%)
1 month | 3 months | 12 months
Get New Calyxt Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CLXT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CLXT

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$9.33
▲ +78.46% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Calyxt in the last 3 months. The average price target is $9.33, with a high forecast of $16.00 and a low forecast of $4.00. The average price target represents a 78.46% upside from the last price of $5.23.
Buy
The current consensus among 6 investment analysts is to buy stock in Calyxt. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/29/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 0 sell ratings
4/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 0 sell ratings
7/25/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
10/23/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings
1/21/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
3/22/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/22/2021Canaccord GenuityReiterated RatingBuy$16.00High
i
2/16/2021Canaccord GenuityBoost Price TargetSell ➝ Buy$8.00 ➝ $16.00Low
i
12/15/2020Berenberg BankInitiated CoverageBuy$9.00Low
i
12/10/2020HC WainwrightInitiated CoverageBuy$10.00Medium
i
Rating by A. Dayal at HC Wainwright
8/13/2020National SecuritiesDowngradeBuy ➝ NeutralHigh
i
7/28/2020Canaccord GenuityInitiated CoverageBuy$8.00N/A
i
5/15/2020Wells Fargo & CompanyLower Price TargetEqual Weight$6.00 ➝ $4.00High
i
Rating by John Baumgartner at Wells Fargo & Company
5/8/2020National SecuritiesReiterated RatingBuy$10.00Medium
i
Rating by Ben Klieve at National Securities
5/8/2020BMO Capital MarketsDowngradeOutperform ➝ Market Perform$13.00 ➝ $7.00Medium
i
3/23/2020Jefferies Financial GroupDowngradeBuy ➝ HoldMedium
i
3/6/2020National SecuritiesReiterated RatingBuy$16.00High
i
Rating by Ben Klieve at National Securities
3/6/2020Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$15.00 ➝ $6.00High
i
3/5/2020The Goldman Sachs GroupDowngradeBuy ➝ Neutral$19.00 ➝ $7.00High
i
2/10/2020National SecuritiesReiterated RatingBuy$16.00Medium
i
Rating by Ben Klieve at National Securities
12/23/2019National SecuritiesReiterated RatingBuy$16.00High
i
11/8/2019BMO Capital MarketsLower Price TargetOutperform$15.00High
i
8/8/2019National SecuritiesReiterated RatingBuy ➝ Buy$35.00 ➝ $28.00High
i
7/26/2019National SecuritiesReiterated RatingBuyLow
i
6/27/2019National SecuritiesReiterated RatingBuy ➝ Buy$35.00 ➝ $35.00High
i
5/9/2019National SecuritiesReiterated RatingBuy ➝ Buy$35.00 ➝ $35.00Low
i
3/13/2019National SecuritiesReiterated RatingBuy ➝ Buy$35.00 ➝ $35.00High
i
3/6/2019National SecuritiesInitiated CoverageBuy ➝ Buy$35.00Low
i
2/27/2019CitigroupBoost Price TargetNeutral ➝ Neutral$13.00 ➝ $16.00Low
i
12/16/2018The Goldman Sachs GroupUpgradeNeutral ➝ Buy$9.25 ➝ $18.00High
i
Rating by Adam Samuelson at The Goldman Sachs Group, Inc.
11/19/2018CitigroupLower Price TargetNeutral ➝ Neutral$19.00 ➝ $13.00Low
i
11/15/2018Jefferies Financial GroupReiterated RatingBuy$27.00Low
i
9/7/2018The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$18.00High
i
6/22/2018Jefferies Financial GroupReiterated RatingBuy$27.00Low
i
3/22/2018Jefferies Financial GroupReiterated RatingBuy$27.00Medium
i
3/1/2018Jefferies Financial GroupReiterated RatingBuy$27.00High
i
12/20/2017LADENBURG THALM/SH SHInitiated CoverageBuy ➝ Buy$34.25High
i
11/16/2017CitigroupLower Price TargetNeutral$27.00 ➝ $22.00N/A
i
11/1/2017Jefferies Financial GroupBoost Price TargetBuy$27.00N/A
i
10/30/2017BMO Capital MarketsInitiated CoverageOutperform$32.00N/A
i
9/29/2017Wells Fargo & CompanyBoost Price TargetOutperform$17.00 ➝ $30.00Medium
i
9/27/2017CitigroupDowngradeBuy ➝ NeutralHigh
i
8/15/2017CitigroupInitiated CoverageBuy ➝ Buy$16.00High
i
8/14/2017Wells Fargo & CompanyInitiated CoverageOutperform ➝ Outperform$17.00High
i
8/14/2017Jefferies Financial GroupInitiated CoverageBuy ➝ Buy$16.00 ➝ $16.00High
i
(Data available from 4/21/2016 forward)
Calyxt logo
Calyxt, Inc., a technology company, focuses on delivering plant-based solutions in the United States. It engages in the development of improved digestibility alfalfa; high fiber wheat; high oleic low linolenic soybeans; winter oats; hemp; fat soybeans; and cold storable potatoes. As of March 4, 2021, the company had nine projects at Phase I stage or later in development across alfalfa, hemp, oats, soybeans, and wheat. Calyxt, Inc. has a research collaboration with NRGene, which includes the adoption of NRGene's cloud-based genomics platform to support various research projects; and a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and various geographies outside the United States. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.
Read More

Today's Range

Now: $5.23
$4.93
$5.37

50 Day Range

MA: $6.94
$5.35
$9.80

52 Week Range

Now: $5.23
$3.16
$12.43

Volume

200,294 shs

Average Volume

299,154 shs

Market Capitalization

$194.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.36

Frequently Asked Questions

What sell-side analysts currently cover shares of Calyxt?

The following sell-side analysts have issued reports on Calyxt in the last twelve months: Berenberg Bank, BMO Capital Markets, Canaccord Genuity, HC Wainwright, National Securities, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for CLXT.

What is the current price target for Calyxt?

6 Wall Street analysts have set twelve-month price targets for Calyxt in the last year. Their average twelve-month price target is $9.33, suggesting a possible upside of 78.5%. Canaccord Genuity has the highest price target set, predicting CLXT will reach $16.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $4.00 for Calyxt in the next year.
View the latest price targets for CLXT.

What is the current consensus analyst rating for Calyxt?

Calyxt currently has 3 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CLXT will outperform the market and that investors should add to their positions of Calyxt.
View the latest ratings for CLXT.

What other companies compete with Calyxt?

How do I contact Calyxt's investor relations team?

Calyxt's physical mailing address is 2800 MOUNT RIDGE ROAD, ROSEVILLE MN, 55113. The company's listed phone number is 651-683-2807 and its investor relations email address is [email protected] The official website for Calyxt is www.calyxt.com.